Aessoa® GLOBAL LIDOCAINE (1×1ML)

How does Aessoa Global work? Aessoa Global Lidocaine is based on a high concentration of monophasic, cross-linked hyaluronic acid, making it an effective dermal filler for the treatment of fine lines and early signs of aging. The filler helps improve skin structure while attracting water molecules to support deep skin hydration and rejuvenation. It is specifically formulated for delicate areas such as periorbital lines and is also suitable for precise lip contouring. AESSOA is a premium monophasic cross-linked hyaluronic acid filler with a concentration of 24 mg/ml and lidocaine, ensuring both effectiveness and patient comfort. Aessoa Global is injected into the mid dermis and has a viscosity complex of 100–200 Pa·s, containing 0.3% lidocaine. Treatment areas Aessoa Global

• Lip contouring
• Periorbital wrinkles

Aessoa Global filler is specifically developed to reduce moderate and superficial wrinkles, correct crow’s feet, and enhance lip volume. Its soft and homogeneous gel allows smooth application and natural-looking results. This dermal filler is of non-animal origin. Its high viscoelasticity helps maintain optimal volume and long-lasting results for up to 12–18 months. Application:

• Reduction of moderate and superficial wrinkles
• Correction of crow’s feet
• Lip enhancement and contouring

Aessoa was introduced in 2020 by Oreon and represents a premium collection of dermal fillers designed for various aesthetic needs. The fillers are based on high concentrations of cross-linked hyaluronic acid. Each product in the Aessoa line is tailored to specific treatment goals, making it a precise tool for aesthetic and anti-aging procedures. The range covers all treatment areas, from fine lines to deep wrinkles and overall skin rejuvenation. The manufacturer of AESSOA fillers is the Korean company AEZIAN Co., Ltd., founded in 2013. All AESSOA products comply with European quality standards and are CE-certified.